Boston Scientific Corporation (BSX) vs Stryker Corporation (SYK)
- Boston Scientific Corporation BSX 43.00 −3.67%
- Stryker Corporation SYK 324.01 −3.30%
Boston Scientific Corporation and Stryker Corporation are both Medical Devices companies. Stryker Corporation is the larger, with a market value of $127.6B against $64.7B — 2.0× the size. Boston Scientific Corporation trades at the lower P/E: 18.7× against 35.3×. Boston Scientific Corporation grew revenue faster over the last twelve months: 8.87% against 7.87%. Boston Scientific Corporation has the higher net margin (16.6% vs 13.8%) and the lower return on invested capital (6.60% vs 9.67%). Across the 22 metrics below, Boston Scientific Corporation leads on 16 and Stryker Corporation on 6.
Valuation
Profitability
| Metric | BSX | SYK | Medical Devices median |
|---|---|---|---|
| Gross margin | 69.14% | 65.34% | 57.76% |
| Operating margin | 18.65% | 20.66% | (15.07%) |
| Net margin | 16.62% | 13.78% | (14.45%) |
| Free cash flow margin | 15.81% | 16.76% | (3.88%) |
| Return on equity | 14.15% | 16.02% | (10.35%) |
| Return on assets | 7.94% | 7.68% | (17.26%) |
| Return on invested capital | 6.60% | 9.67% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack